Han Na Kang

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer

Jiyeon Yun, Min Hee Hong, Seok‐Young Kim et al. · Clinical Cancer Research · 2019 · 126 citations · Full text

Medicine, Oncology, Pharmacology +14

Metastatic function of BMP-2 in gastric cancer cells: The role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression

Myoung Hee Kang, Sang Cheul Oh, Hyun Joo Lee et al. · Experimental Cell Research · 2011 · 116 citations

Medicine, Cell Biology, Oncology +15

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer

Mi Ran Yun, Hun Mi Choi, You Won Lee et al. · EMBO Molecular Medicine · 2019 · 61 citations · Full text

Medicine, Oncology, Pharmacology +14

The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression

Jaebeom Cho, Su Jung Hwang, Hye‐Young Min et al. · Cancer Research · 2020 · 48 citations · Full text

Medicine, Cell Biology, Oncology +17

Mouse–human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

Hye Ryun Kim, Han Na Kang, Mi Ran Yun et al. · British Journal of Cancer · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15